Stock CSBR CHAMPIONS ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Delayed Nasdaq
Other stock markets
 10:24:41 2024-07-10 am EDT 		5-day change 1st Jan Change
5.15 USD +2.79% Intraday chart for Champions Oncology, Inc. +6.19% -8.36%
Jun. 04 Champions Oncology, Inc and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development CI
Mar. 15 Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Champions Oncology, Inc and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
CI
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
CI
Craig-Hallum Downgrades Champions Oncology to Hold From Buy
MT
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024
CI
Transcript : Champions Oncology, Inc., Q3 2024 Earnings Call, Mar 12, 2024
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation
AQ
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
CI
Craig Hallum Trims Champions Oncology Price target to $9 From $10, Maintains Buy Rating
MT
Transcript : Champions Oncology, Inc., Q2 2024 Earnings Call, Dec 12, 2023
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023
CI
MORNING BID AMERICAS-Disinflation station
RE
North American Morning Briefing : Traders Eye -2-
DJ
Champions Oncology, Inc.
AQ
Champions Oncology Announces the Addition of Brady Davis as President
AQ
Champions Oncology, Inc. Appoints Brady Davis as President
CI
Roth MKM Adjusts Price Target on Champions Oncology to $7.50 From $9, Maintains Buy Rating
MT
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.
CI
Transcript : Champions Oncology, Inc., Q1 2024 Earnings Call, Sep 13, 2023
Champions Oncology : Reports Quarterly Revenue of $12.6 Million - Form 8-K
PU
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSBR Stock
  4. News Champions Oncology, Inc.